Results 221 to 230 of about 1,092,122 (354)

Machine Learning for Predicting Chronic Renal Disease Progression in COVID-19 Patients with Acute Renal Injury: A Feasibility Study. [PDF]

Biomedicines
Gracida-Osorno C, Molina-Salinas GM, Góngora-Hernández R, Brito-Loeza C, Uc-Cachón AH, Paniagua-Sierra JR.   +5 more
europepmc   +1 more source

PhysIOpathology of NEuromuscular function rElated to fatigue in chronic Renal disease in the elderly (PIONEER): study protocol. [PDF]

BMC Nephrol, 2020
Chatrenet A, Beaune B, Fois A, Pouliquen C, Audebrand JM, Torreggiani M, Paris D, Durand S, Piccoli GB.   +8 more
europepmc   +1 more source

Pica behaviors in patients with chronic kidney disease: A review / Conductas de pica en pacientes con enfermedad renal crónica: Una revisión

, 2022
Isaías Vicente Lugo-González, Yuma Yoaly Pérez Bautista   +1 more
openalex   +2 more sources

Neurocognitive functions and educational outcomes in children with chronic renal disease. [PDF]

, 2020
Sawsan Sayed Elmoselhy, Reham M. Elhossiny, Mohammad Sharaf, Hossam Moussa Sakr, M.H. Youssef, Noha Fahim   +5 more
openalex   +1 more source

Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects

Advanced Materials, EarlyView.
Mesoporous silica nanoparticles offer unique properties like high surface area, tunable pores, and functionalization. They excel in drug delivery, tissue engineering, and stimuli‐responsive therapies, enabling targeted and controlled treatments. With roles in cancer therapy and diagnostics, their clinical translation requires addressing challenges in ...
Miguel Manzano, María Vallet‐Regí
wiley   +1 more source

Clinical value of retinol binding protein, C-reactive protein and urine microalbumin in patients with chronic renal disease and ischemic cerebrovascular disease. [PDF]

Am J Transl Res
Wu H, Li L.
europepmc   +1 more source

Tailoring Advanced Metal‐Based Nanomedicines for Adaptable Nanodynamic Disease Therapies and Theranostics

Advanced Materials, EarlyView.
This review summarizes recent advances in metal‐based nanomaterials (MBNs) as multifunctional platforms for next‐generation diagnostics and nanodynamic therapies (NDTs), highlighting their structural tunability, diverse therapeutic modalities, and broad biomedical applications in oncology and infectious disease control.
Qihang Ding, Wenhao Li, Ling Mei, Suling Luo, Jing Tao, Chongxiu Shi, Hongping Yang, Wei Feng, Yungchang Chen, Yu Chen, Jong Seung Kim, Xue Shen   +11 more
wiley   +1 more source

Plant-based diets in chronic kidney disease: Potential benefits and risks in renal function management [PDF]

Paweł Godlewski, Anna Gwóźdź-Broczkowska, Bartosz Górecki, Aisha Hassan, Sara Hassan, Szymon Bienia   +5 more
openalex   +1 more source

Aluminum-associated bone disease in chronic renal failure: High prevalence in a long-term dialysis population [PDF]

, 1986
Dennis L. Andress, Norma A. Maloney, David B. Endres, Donald J. Sherrard   +3 more
openalex   +1 more source

Lithium‐Charged Gold Nanoparticles: A New Powerful Tool for Lithium Delivery and Modulation of Glycogen Synthase Kinase 3 Activity

Advanced Materials, EarlyView.
This study introduces glutathione‐stabilized gold nanoparticles for targeted lithium delivery (LiG‐AuNPs), enabling the controlled modulation of Glycogen Synthase Kinase‐3 (GSK‐3β). These non‐toxic, 2‐nm particles release lithium intracellularly, effectively inhibiting GSK‐3β in the brain without significant plasma lithium alterations.
Antonio Buonerba, Giulia Puliatti, Domenica Donatella Li Puma, Bruno Bandiera, Beatrice Cannata, Maria Elena Marcocci, Nicolina Castagno, Irene Contento, Salvatore Impemba, Mariarosa Scognamiglio, Rocco Di Girolamo, Vincenzo Naddeo, Patrizia Canton, Carmine Capacchione, Laura Sposito, Martina Albini, Francesco Pastore, Silvia Baroni, Alfonso Grassi, Claudio Grassi, Roberto Piacentini   +20 more
wiley   +1 more source